<?xml version="1.0" encoding="UTF-8"?>

<?xml-stylesheet type="text/xsl" href="/static/oaitohtml.xsl"?>

<!--
<?xml-stylesheet type="text/xsl" href="/oaitohtml.xsl"?>
-->

<OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <responseDate>2026-10-13T11:58:52Z</responseDate>
    <request verb="GetRecord" metadataPrefix="oai_dc" identifier="10.57760/sciencedb.40339" >https://www.scidb.cn/oai</request>
<GetRecord>
    <record>
    <header >
    <identifier>10.57760/sciencedb.40339</identifier>
    <datestamp>2026-06-24T19:16:45Z</datestamp>
</header>
    <metadata>
        
<oai_dc:dc xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
  <dc:date>2026-06-24</dc:date>
  <dc:title>A unique intestinal desensitization strategy: Blocking membrane protease enrichment on macrophages by helminth-derived cystatin-like protein</dc:title>
  <dc:identifier>doi:10.57760/sciencedb.40339</dc:identifier>
  <dc:language>en</dc:language>
  <dc:description>	Egg allergies are prevalent worldwide and pose serious risks in children; however, a permanent cure is lacking. The desensitization of Trichinella spiralis-secreted cystatin-like protein (Ts-CLP) is an alternative to helminthic therapy for food allergies. Based on the allergy model in which Escherichia coli (E. coli) delivers ovalbumin (OVA) to the digestive system of OT-II mice, various therapeutic interventions related to Ts-CLP partially (delayed bone marrow-derived macrophages (BMDMs) intervention) or completely relieved inflammation and the disease course. Mechanistically, protein‒macrophage interaction-mediated blockade of the membrane enrichment of plasmin was identified as the important mode by which Ts-CLP-induced regulation manifests as high-level immunosuppressive cytokine secretion and impaired T-cell recruitment. In summary, Ts-CLP-incubated BMDMs can serve as an alternative for inflammation intervention in OVA-induced intestinal allergic diseases and the strategy of blocking protease enrichment on cell membrane is feasible to be applied in the treatment of type II inflammatory diseases.</dc:description>
  <dc:subject>food allergy; helminthic therapy; alternative activated macrophages; receptor competitive binding; Trichinella spiralis</dc:subject>
  <dc:creator>wenjie shi</dc:creator>
  <dc:rights>PUBLIC</dc:rights>
  <dc:rights>https://creativecommons.org/licenses/by/4.0/</dc:rights>
  <dc:type>dataset</dc:type>
  <dc:publisher>Science Data Bank</dc:publisher>
</oai_dc:dc>

    </metadata>
</record>
</GetRecord>
</OAI-PMH>